相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu et al.
THERANOSTICS (2022)
Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer
Hongyi Chen et al.
BIOMATERIALS (2022)
Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer
Mubin Tarannum et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer
Girgis Obaid et al.
ADVANCED SCIENCE (2022)
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
Dharambir Kashyap et al.
SEMINARS IN CANCER BIOLOGY (2021)
Polyanhydride nanoparticles stabilize pancreatic cancer antigenMUC4β
Luman Liu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2021)
Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer
Siyuan Tang et al.
MOLECULAR PHARMACEUTICS (2021)
Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma
Xi Hu et al.
ADVANCED SCIENCE (2021)
Exosomes as new therapeutic vectors for pancreatic cancer treatment
Constanca Oliveira et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
Juan Gonzalez-Valdivieso et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Yongmei Zhao et al.
PHARMACEUTICS (2021)
Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes
Rami Alzhrani et al.
ADVANCED THERAPEUTICS (2021)
Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy
Ying Xie et al.
ACS NANO (2020)
Challenges in nanomedicine clinical translation
Josbert M. Metselaar et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities
Won Jin Ho et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Protein arginine methylation promotes therapeutic resistance in human pancreatic cancer
Victoria Katie Xie et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Molecular mediators of peritoneal metastasis in pancreatic cancer
Leela Rani Avula et al.
CANCER AND METASTASIS REVIEWS (2020)
Immunotherapy for pancreatic cancer: A 2020 update
Dimitrios Schizas et al.
CANCER TREATMENT REVIEWS (2020)
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?
Bolun Jiang et al.
FRONTIERS IN ONCOLOGY (2020)
Early Diagnosis of Pancreatic Cancer: The Key for Survival
Gina Gheorghe et al.
DIAGNOSTICS (2020)
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
Gouri Pandya et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Exosomes as therapeutic solutions for pancreatic cancer
Batoul Farran et al.
DRUG DISCOVERY TODAY (2020)
Noncoding RNAs in drug-resistant pancreatic cancer: A review
Zhengjun Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer
Kruti S. Soni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Pancreatic Adenocarcinoma, Version 1.2019
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical effectiveness of combined interventional therapy as a salvage modality for unresectable pancreatic carcinoma
Sushant Kumar Das et al.
ONCOLOGY LETTERS (2019)
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival
Ludmila Danilova et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer
Sheema Khan et al.
BIOMATERIALS (2019)
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures
Hongliang He et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC
R. Govindan et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Macarulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release
Chao Kong et al.
ACS NANO (2019)
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Recent advances in metal nanoparticles in cancer therapy
Ankush Sharma et al.
JOURNAL OF DRUG TARGETING (2018)
Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology
Catherine M. Sielaff et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy
Xi He et al.
ADVANCED SCIENCE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
Zhongyi Guo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
Sangiliyandi Gurunathan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Applications of Noble Metal-Based Nanoparticles in Medicine
Bartosz Klebowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure
Steven K. Libutti et al.
Oncotarget (2018)
Cancer nanomedicines: oversold or underappreciated?
Roy van der Meel et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
MicroRNA in pancreatic cancer
Keiichi Yonemori et al.
JOURNAL OF HUMAN GENETICS (2017)
Immunotherapy of cancers comes of age
Hila Yousefi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases
Xinzhe Yu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment
Haijie Han et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Design and Synthesis of Dendrimers with Facile Surface Group Functionalization, and an Evaluation of Their Bactericidal Efficacy
Elizabeth Ladd et al.
MOLECULES (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters
Patricia Dauer et al.
PANCREATOLOGY (2017)
Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding
Wei Ge et al.
ONCOTARGET (2017)
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
Meng Zhang et al.
CANCER BIOLOGY & MEDICINE (2017)
Nanotechnologies in Pancreatic Cancer Therapy
Ayesha Manzur et al.
PHARMACEUTICS (2017)
Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers
Abdullah K. Alshememry et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies
Ana Rebelo et al.
CURRENT DRUG METABOLISM (2017)
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
Carlos Urey et al.
ANTICANCER RESEARCH (2017)
Advances in the Genetics and Biology of Pancreatic Cancer
Andrew J. Aguirre et al.
CANCER JOURNAL (2017)
Terminating the criminal collaboration in pancreatic cancer: Nanoparticle-based synergistic therapy for overcoming fibroblast induced drug resistance
Liying Wang et al.
BIOMATERIALS (2017)
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
Carlotta Borsoi et al.
CANCER LETTERS (2017)
Effect of Terminal-Group Functionality on the Ability of Dendrimers to Bind Proteins
Fumiko Chiba et al.
BIOCONJUGATE CHEMISTRY (2017)
Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development
Stephan B. Dreyer et al.
CLINICAL CANCER RESEARCH (2017)
Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT)
Arndt Vogel et al.
BMC CANCER (2016)
Surgical and molecular pathology of pancreatic neoplasms
Wenzel M. Hackeng et al.
DIAGNOSTIC PATHOLOGY (2016)
Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer
Yueling Yuan et al.
DRUG DELIVERY (2016)
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Andrea Wang-Gillam et al.
LANCET (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Amira Elgogary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+Stem-Like Pancreatic Cancer Cells
Prashant Kesharwani et al.
BIOMACROMOLECULES (2015)
Nanoparticle formulation of ormeloxifene for pancreatic cancer
Sheema Khan et al.
BIOMATERIALS (2015)
Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: Overcoming transport defects using a nanoparticle approach
Sau Wai Hung et al.
CANCER LETTERS (2015)
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Yoav Binenbaum et al.
DRUG RESISTANCE UPDATES (2015)
Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice
Yanyun Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer
Christopher Poon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Pathological and Molecular Evaluation of Pancreatic Neoplasms
Arvind Rishi et al.
SEMINARS IN ONCOLOGY (2015)
MUC4-induced nuclear translocation of β-catenin: A novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer
Xiaofei Zhi et al.
CANCER LETTERS (2014)
Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
Armando Lucero-Acuna et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Pancreatic Adenocarcinoma
David P. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Nanodrug delivery in reversing multidrug resistance in cancer cells
Sonali Kapse-Mistry et al.
FRONTIERS IN PHARMACOLOGY (2014)
Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer
Joshua McCarroll et al.
Frontiers in Physiology (2014)
Aphid polyphenisms: trans-generational developmental regulation through viviparity
Kota Ogawa et al.
FRONTIERS IN PHYSIOLOGY (2014)
A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
Peter J. Hosein et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Roles for KRAS in Pancreatic Tumor Development and Progression
Marina Pasca di Magliano et al.
GASTROENTEROLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Differences in Transcript Levels of ABC Transporters Between Pancreatic Adenocarcinoma and Nonneoplastic Tissues
Beatrice Mohelnikova-Duchonova et al.
PANCREAS (2013)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
pH sensing and regulation in cancer
Mehdi Damaghi et al.
FRONTIERS IN PHYSIOLOGY (2013)
Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
Vincenzo Corbo et al.
CURRENT DRUG TARGETS (2012)
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Priyambada Parhi et al.
DRUG DISCOVERY TODAY (2012)
Cancer stem cells
Zuoren Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
The Upcoming Field of Theranostic Nanomedicine: An Overview
Priyanka Prabhu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2012)
Challenges to effective cancer nanotheranostics
Marites P. Melancon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Polymeric micelles drug delivery system in oncology
Jian Gong et al.
JOURNAL OF CONTROLLED RELEASE (2012)
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
Mert Erkan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach
Makoto Yoshida et al.
PLOS ONE (2012)
Treating metastatic cancer with nanotechnology
Avi Schroeder et al.
NATURE REVIEWS CANCER (2012)
Utilisation of Nanoparticle Technology in Cancer Chemoresistance
Duncan Ayers et al.
JOURNAL OF DRUG DELIVERY (2012)
Nanomedicine in cancer therapy: Innovative trends and prospects
Elvin Blanco et al.
CANCER SCIENCE (2011)
Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in Stem-Cell-Like Tumor Cells
Zhiyong Du et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Steven K. Libutti et al.
CLINICAL CANCER RESEARCH (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-α
Matthew Kraman et al.
SCIENCE (2010)
Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
Yiwei Li et al.
CANCER RESEARCH (2009)
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
Zhiwei Wang et al.
CANCER RESEARCH (2009)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam et al.
CANCER RESEARCH (2009)
NF-κB and epithelial to mesenchymal transition of cancer
Chengyin Min et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis
Z. N. Demidenko et al.
ONCOGENE (2008)
Biology and management of pancreatic cancer
P. Ghaneh et al.
POSTGRADUATE MEDICAL JOURNAL (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
Patrick C. Hermann et al.
CELL STEM CELL (2007)
Biology and management of pancreatic cancer
Paula Ghaneh et al.
GUT (2007)
A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation
T. Hamaguchi et al.
BRITISH JOURNAL OF CANCER (2007)
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
TNF-α in cancer treatment:: Molecular insights, antitumor effects, and clinical utility
Remco van Horssen et al.
ONCOLOGIST (2006)
New target therapies in advanced pancreatic cancer
S. Cascinu et al.
ANNALS OF ONCOLOGY (2006)
Differential diagnosis of pancreatic tumors using ultrasound contrast imaging
A Sofuni et al.
JOURNAL OF GASTROENTEROLOGY (2005)
The genetics of pancreatic cancer
SM Cowgill et al.
AMERICAN JOURNAL OF SURGERY (2003)
Pancreatic cancer biology and genetics
N Bardeesy et al.
NATURE REVIEWS CANCER (2002)
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
JD Berlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
